131 related articles for article (PubMed ID: 9372533)
1. Use of antisense oligodeoxynucleotide to delta-opioid receptor mRNA in the study of turnover of delta-opioid receptors in the spinal cord of the mouse.
Narita M; Mizoguchi H; Nagase H; Tseng LF
Psychopharmacology (Berl); 1997 Oct; 133(4):347-50. PubMed ID: 9372533
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of spinal delta-opioid receptors in mice selectively enhances the attenuation of delta-opioid receptor-mediated antinociception by antisense oligodeoxynucleotide.
Narita M; Tseng LF
Eur J Pharmacol; 1995 Sep; 284(1-2):185-9. PubMed ID: 8549623
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse.
Wang HQ; Kampine JP; Tseng LF
Neuroscience; 1996 Nov; 75(2):445-52. PubMed ID: 8931008
[TBL] [Abstract][Full Text] [Related]
4. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with beta-endorphin facilitates the attenuation of delta-opioid receptor-mediated antinociception caused by delta-opioid receptor antisense oligodeoxynucleotide.
Tseng LF; Narita M; Kampine JP
Eur J Pharmacol; 1995 Dec; 287(2):169-72. PubMed ID: 8749031
[TBL] [Abstract][Full Text] [Related]
6. Use of antisense oligodeoxynucleotide to determine delta-opioid receptor involvement in [D-Ala2]deltorphin II-induced locomotor hyperactivity.
Mizoguchi H; Narita M; Nagase H; Suzuki T; Quock RM; Tseng LF
Life Sci; 1996; 59(4):PL69-73. PubMed ID: 8761010
[TBL] [Abstract][Full Text] [Related]
7. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
8. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J
Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351
[TBL] [Abstract][Full Text] [Related]
10. Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively.
Takemori AE; Portoghese PS
Eur J Pharmacol; 1993 Sep; 242(2):145-50. PubMed ID: 8253111
[TBL] [Abstract][Full Text] [Related]
11. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
[TBL] [Abstract][Full Text] [Related]
12. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
13. Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice.
Lee CE; Kest B; Jenab S; Inturrisi CE
Brain Res Mol Brain Res; 1997 Aug; 48(1):17-22. PubMed ID: 9379841
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligodeoxynucleotide to a delta-opioid receptor blocks the antinociception induced by cold water swimming.
Mizoguchi H; Narita M; Nagase H; Tseng LF
Regul Pept; 1995 Oct; 59(2):255-9. PubMed ID: 8584762
[TBL] [Abstract][Full Text] [Related]
15. Spinal delta 2 but not delta 1 opioid receptors are involved in intracerebroventricular beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA; Portoghese PS
Life Sci; 1993; 52(19):PL211-5. PubMed ID: 8387138
[TBL] [Abstract][Full Text] [Related]
16. 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord.
Sofuoglu M; Portoghese PS; Takemori AE
Life Sci; 1993; 52(8):769-75. PubMed ID: 8383271
[TBL] [Abstract][Full Text] [Related]
17. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
18. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
[TBL] [Abstract][Full Text] [Related]
19. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
[TBL] [Abstract][Full Text] [Related]
20. Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss Webster mice.
Rady JJ; Baemmert D; Takemori AE; Portoghese PS; Fujimoto JM
Pharmacol Biochem Behav; 1997 Feb; 56(2):243-9. PubMed ID: 9050081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
